Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Tool Can Predict Individual’s Risk of Psychotic Disorders

July 5, 2016 By Beth Israel Deaconess Medical Center

A new risk calculator can predict an individual’s risk of developing psychotic disorders such as schizophrenia, according to a new study published in The American Journal of Psychiatry. The research involved collaborators from nine sites, including Beth Israel Deaconess Medical Center, and may help researchers test treatments to prevent onset of full psychosis.

Psychosis is characterized by hallucinations and delusions. The new calculator assesses an individual’s risk of developing psychosis after experiencing early warning signs of schizophrenia, such as hearing voices. 

“Until now, clinicians could give patients only a rough estimate of how their condition might progress — that some 15 to 25 percent of people who have experienced early warning symptoms will go on to develop a more serious disorder,” said Larry J. Seidman, PhD, a psychologist at Beth Israel Deaconess and professor of psychology at Harvard Medical School. “With this new risk calculator, clinicians can now give patients an individualized assessment of risk. More precise information allows people to have a more realistic sense of what’s going on, which can reduce anxiety.”

In addition to stressful life events, trauma and family history of schizophrenia and, the calculator takes into account five other factors to determine an individual’s level of risk. These factors include: Age of onset of symptoms; levels of unusual thought content and suspiciousness; social functioning; verbal learning skills; and speed of mental processing. 

Seidman and his colleagues analyzed data from interviews with 596 subjects, ages 12 to 35 years, who were diagnosed with attenuated psychosis syndrome, a condition in which patients may experience hallucinations and/or develop unusual thoughts but recognize their perceptions aren’t based in reality.

The research team, led by Yale University’s Tyrone Cannon, PhD, then developed the risk calculator, which analyzes known risk factors for schizophrenia. After following up with the subjects every six months, the researchers found that 16 percent of the patients diagnosed with attenuated psychosis syndrome had converted to psychosis within two years. 

Symptoms of unusual thought content and suspiciousness contributed most to the risk of developing psychosis. A decline in social functioning, lower verbal learning and slower processing speed were also significant factors.

People who were younger (in their teens or early twenties) when their symptoms began, were also at increased risk. Stressful life events, traumas and family history of schizophrenia turned out to have a lower impact on an individual’s risk profile. 

“The risk calculator does not take into account treatment or other potentially supportive environmental factors that may reduce risk; this is a direction for future research,” Seidman said, adding that the power of the calculator lies in putting symptoms in perspective for patients and their families. “Having hallucinations, it turns out, doesn’t add much predictive weight at all. Maybe this person has good cognitive function and has not declined socially — this profile would lead to a good score. Treatment can ensue, potentially with less fear.” 

This work was funded by grants from the National Institutes of Health, National Institute of Mental Health, and support from the Center of Excellence in Clinical Neuroscience and Psychopharmacological Research of the Massachusetts Department of Mental Health.

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe